|
Bacillus coagulans
|
B03.353.500.100.218.314 |
|
|
Cystine-Knot Miniproteins
|
D12.776.217 |
|
|
Tertiary Prevention
|
N06.850.780.800 |
|
|
Smad2 Protein
|
D051899 |
[A receptor-regulated smad protein that undergoes PHOSPHORYLATION by ACTIVIN RECEPTORS, TYPE I. It regulates TRANSFORMING GROWTH FACTOR BETA and ACTIVIN signaling.
] |
|
Micronucleus Tests
|
E05.393.560.598 |
|
|
Observer Variation
|
N02.421.450.600 |
|
|
Kininogens
|
D23.119.630 |
|
|
Krukenberg Tumor
|
C04.557.470.590.415.410 |
|
|
Schools, Nursery
|
J03.832.660 |
|
|
Mantodea
|
B01.050.500.131.617.720.500.750 |
|
|
Depressive Disorder, Treatment-Resistant
|
D061218 |
[Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)
] |
|
Breast Neoplasms, Male
|
C17.800.090.500.260 |
|
|
Olfactory Nerve Injuries
|
D061219 |
[Traumatic injuries to the OLFACTORY NERVE. It may result in various olfactory dysfunction including a complete loss of smell.
] |
|
Potassium Ionophores
|
D061216 |
[Chemical agents that increase the permeability of CELL MEMBRANES to POTASSIUM ions.
] |
|
Weight Reduction Programs
|
D061217 |
[Services providing counseling and activities that help overweight individuals to attain a more healthy body weight.
] |
|
Patient Safety
|
D061214 |
[Efforts to reduce risk, to address and reduce incidents and accidents that may negatively impact healthcare consumers.
] |
|
Sodium Channel Agonists
|
D27.505.519.562.625 |
|
|
Targeted Gene Repair
|
E05.393.420.301.500 |
|
|
Genetic Therapy
|
E05.393.420.301 |
|
|
Maxillary Sinus
|
A04.531.621.578 |
|
